NCT06427941 2026-04-17
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
BeOne Medicines
Phase 1 Recruiting
Clinical Trials
9 trialsNCT06795022 2026-04-06
RHEA-1
AstraZeneca
Phase 1/2 Recruiting
NCT07500220 2026-03-30
DUET-HCC
Beijing Biotech
Phase 1/2 Recruiting
NCT06687941 2026-03-27
A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors
Aptamer Sciences, Inc.
Phase 1 Recruiting
NCT04928677 2026-02-17
A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT06715839 2025-12-31
Target-specific immunoPET Imaging of Digestive System Carcinoma
RenJi Hospital
Phase NA Recruiting
NCT06478693 2025-12-18
A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
Myeloid Therapeutics
Phase 1 Recruiting
NCT05263830 2025-12-16
IMMUNOGLYPIC
Assistance Publique - Hôpitaux de Paris
Recruiting
NCT03198546 2024-06-25
GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression
Second Affiliated Hospital of Guangzhou Medical University
Phase 1 Recruiting